Articles

Florijn, B. W.; Duijs, J. M. G. J.; Levels, J. H.; Dallinga-Thie, G. M.; Wang, Y.; Boing, A. N.; Yuana, Y.; Stam, W.; Limpens, R. W. A. L.; Au, Y. W.; et al. Diabetic nephropathy alters the distribution of circulating angiogenic microRNAs among extracellular vesicles, HDL, and Ago-2. Diabetes 2019, 68 (12), 2287-2300.

Florijn BW, Duijs JMGJ, Levels JH, et al. Diabetic nephropathy alters the distribution of circulating angiogenic microRNAs among extracellular vesicles, HDL, and Ago-2. Diabetes. 2019;68(12):2287-2300.

B. W. Florijn et al., “Diabetic nephropathy alters the distribution of circulating angiogenic microRNAs among extracellular vesicles, HDL, and Ago-2,” Diabetes, vol. 68, no. 12, pp. 2287-2300, Dec. 2019.

Florijn BW, Duijs JMGJ, Levels JH, Dallinga-Thie GM, Wang Y, Boing AN, et al. Diabetic nephropathy alters the distribution of circulating angiogenic microRNAs among extracellular vesicles, HDL, and Ago-2. Diabetes. 2019 Dec;68(12):2287-2300.

Berckmans, R. J.; Lacroix, R.; Hau, C. M.; Sturk, A.; Nieuwland, R. Extracellular vesicles and coagulation in blood from healthy humans revisited. J. Extracell. Vesicles 2019, 8 (1), 1688936.

Berckmans RJ, Lacroix R, Hau CM, Sturk A, Nieuwland R. Extracellular vesicles and coagulation in blood from healthy humans revisited. J Extracell Vesicles. 2019;8(1):1688936.

R. J. Berckmans, R. Lacroix, C. M. Hau, A. Sturk, and R. Nieuwland, “Extracellular vesicles and coagulation in blood from healthy humans revisited,” J. Extracell. Vesicles, vol. 8, no. 1, pp. 1688936, Nov. 2019.

Berckmans RJ, Lacroix R, Hau CM, Sturk A, Nieuwland R. Extracellular vesicles and coagulation in blood from healthy humans revisited. J Extracell Vesicles. 2019 Nov;8(1):1688936.

van Manen, L.; Peters, A. L.; van der Sluijs, P. M.; Nieuwland, R.; van Bruggen, R.; Juffermans, N. P. Clearance and phenotype of extracellular vesicles after red blood cell transfusion in a human endotoxemia model. Transfus. Apher. Sci. 2019, 58 (4), 508-511.

van Manen L, Peters AL, van der Sluijs PM, Nieuwland R, van Bruggen R, Juffermans NP. Clearance and phenotype of extracellular vesicles after red blood cell transfusion in a human endotoxemia model. Transfus Apher Sci. 2019;58(4):508-511.

L. van Manen, A. L. Peters, P. M. van der Sluijs, R. Nieuwland, R. van Bruggen, and N. P. Juffermans, “Clearance and phenotype of extracellular vesicles after red blood cell transfusion in a human endotoxemia model,” Transfus. Apher. Sci., vol. 58, no. 4, pp. 508-511, Aug. 2019.

van Manen L, Peters AL, van der Sluijs PM, Nieuwland R, van Bruggen R, Juffermans NP. Clearance and phenotype of extracellular vesicles after red blood cell transfusion in a human endotoxemia model. Transfus Apher Sci. 2019 Aug;58(4):508-511.

Nieuwland, R.; Gardiner, C.; Dignat-George, F.; Mullier, F.; Mackman, N.; Woodhams, B.; Thaler, J. Toward standardization of assays measuring extracellular vesicle-associated tissue factor activity. J. Thromb. Haemost. 2019, 17 (8), 1261-1264.

Nieuwland R, Gardiner C, Dignat-George F, et al. Toward standardization of assays measuring extracellular vesicle-associated tissue factor activity. J Thromb Haemost. 2019;17(8):1261-1264.

R. Nieuwland et al., “Toward standardization of assays measuring extracellular vesicle-associated tissue factor activity,” J. Thromb. Haemost., vol. 17, no. 8, pp. 1261-1264, Aug. 2019.

Nieuwland R, Gardiner C, Dignat-George F, Mullier F, Mackman N, Woodhams B, et al. Toward standardization of assays measuring extracellular vesicle-associated tissue factor activity. J Thromb Haemost. 2019 Aug;17(8):1261-1264.

Kastelein, A. W.; Vos, L. M. C.; de Jong, K. H.; van Baal, J. O. A. M.; Nieuwland, R.; van Noorden, C. J. F.; Roovers, J. W. R.; Lok, C. A. R. Embryology, anatomy, physiology and pathophysiology of the peritoneum and the peritoneal vasculature. Semin. Cell Dev. Biol. 2019, 92 (2019), 27-36.

Kastelein AW, Vos LMC, de Jong KH, et al. Embryology, anatomy, physiology and pathophysiology of the peritoneum and the peritoneal vasculature. Semin Cell Dev Biol. 2019;92(2019):27-36.

A. W. Kastelein et al., “Embryology, anatomy, physiology and pathophysiology of the peritoneum and the peritoneal vasculature,” Semin. Cell Dev. Biol., vol. 92, no. 2019, pp. 27-36, Aug. 2019.

Kastelein AW, Vos LMC, de Jong KH, van Baal JOAM, Nieuwland R, van Noorden CJF, et al. Embryology, anatomy, physiology and pathophysiology of the peritoneum and the peritoneal vasculature. Semin Cell Dev Biol. 2019 Aug;92(2019):27-36.

Horrevorts, S. K.; Stolk, D. A.; van de Ven, R.; Hulst, M.; van het Hof, B.; Duinkerken, S.; Heineke, M. H.; Ma, W.; Dusoswa, S. A.; Nieuwland, R.; et al. Glycan-modified apoptotic melanoma-derived extracellular vesicles as antigen source for anti-tumor vaccination. Cancers 2019, 11 (9), 1266.

Horrevorts SK, Stolk DA, van de Ven R, et al. Glycan-modified apoptotic melanoma-derived extracellular vesicles as antigen source for anti-tumor vaccination. Cancers. 2019;11(9):1266.

S. K. Horrevorts et al., “Glycan-modified apoptotic melanoma-derived extracellular vesicles as antigen source for anti-tumor vaccination,” Cancers, vol. 11, no. 9, pp. 1266, Aug. 2019.

Horrevorts SK, Stolk DA, van de Ven R, Hulst M, van het Hof B, Duinkerken S, et al. Glycan-modified apoptotic melanoma-derived extracellular vesicles as antigen source for anti-tumor vaccination. Cancers. 2019 Aug;11(9):1266.

Dusoswa, S. A.; Horrevorts, S. K.; Ambrosini, M.; Kalay, H.; Paauw, N. J.; Nieuwland, R.; Pegtel, M. D.; Würdinger, T.; Van Kooyk, Y.; Garcia-Vallejo, J. J. Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells. J. Extracell. Vesicles 2019, 8 (1), 1648995.

Dusoswa SA, Horrevorts SK, Ambrosini M, et al. Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells. J Extracell Vesicles. 2019;8(1):1648995.

S. A. Dusoswa et al., “Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells,” J. Extracell. Vesicles, vol. 8, no. 1, pp. 1648995, Aug. 2019.

Dusoswa SA, Horrevorts SK, Ambrosini M, Kalay H, Paauw NJ, Nieuwland R, et al. Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells. J Extracell Vesicles. 2019 Aug;8(1):1648995.

Clayton, A.; Boilard, E.; Buzas, E. I.; Cheng, L.; Falcón-Perez, J. M.; Gardiner, C.; Gustafson, D.; Gualerzi, A.; Hendrix, A.; Hoffman, A.; et al. Considerations towards a roadmap for collection, handling and storage of blood extracellular vesicles. J. Extracell. Vesicles 2019, 8 (1), 1647027.

Clayton A, Boilard E, Buzas EI, et al. Considerations towards a roadmap for collection, handling and storage of blood extracellular vesicles. J Extracell Vesicles. 2019;8(1):1647027.

A. Clayton et al., “Considerations towards a roadmap for collection, handling and storage of blood extracellular vesicles,” J. Extracell. Vesicles, vol. 8, no. 1, pp. 1647027, Aug. 2019.

Clayton A, Boilard E, Buzas EI, Cheng L, Falcón-Perez JM, Gardiner C, et al. Considerations towards a roadmap for collection, handling and storage of blood extracellular vesicles. J Extracell Vesicles. 2019 Aug;8(1):1647027.

Naik, J.; Hau, C. M.; ten Bloemendaal, L.; Mok, K. S.; Hajji, N.; Wehman, A. M.; Meisner, S.; Muncan, V.; Paauw, N. J.; de Vries, H. E.; et al. The P4-ATPase ATP9A is a novel determinant of exosome release. Plos One 2019, 14 (4), e0213069.

Naik J, Hau CM, ten Bloemendaal L, et al. The P4-ATPase ATP9A is a novel determinant of exosome release. Plos One. 2019;14(4):e0213069.

J. Naik et al., “The P4-ATPase ATP9A is a novel determinant of exosome release,” Plos One, vol. 14, no. 4, pp. e0213069, Apr. 2019.

Naik J, Hau CM, ten Bloemendaal L, Mok KS, Hajji N, Wehman AM, et al. The P4-ATPase ATP9A is a novel determinant of exosome release. Plos One. 2019 Apr;14(4):e0213069.

Ayers, L.; Pink, R.; Carter, D. R. F.; Nieuwland, R. Clinical requirements for extracellular vesicle assays. J. Extracell. Vesicles 2019, 8 (1), 1593755.

Ayers L, Pink R, Carter DRF, Nieuwland R. Clinical requirements for extracellular vesicle assays. J Extracell Vesicles. 2019;8(1):1593755.

L. Ayers, R. Pink, D. R. F. Carter, and R. Nieuwland, “Clinical requirements for extracellular vesicle assays,” J. Extracell. Vesicles, vol. 8, no. 1, pp. 1593755, Mar. 2019.

Ayers L, Pink R, Carter DRF, Nieuwland R. Clinical requirements for extracellular vesicle assays. J Extracell Vesicles. 2019 Mar;8(1):1593755.

Rikkert, L. G.; Nieuwland, R.; Terstappen, L. W. M. M.; Coumans, F. A. W. Quality of extracellular vesicle images by transmission electron microscopy is operator and protocol dependent. J. Extracell. Vesicles 2019, 8 (1), 1555419.

Rikkert LG, Nieuwland R, Terstappen LWMM, Coumans FAW. Quality of extracellular vesicle images by transmission electron microscopy is operator and protocol dependent. J Extracell Vesicles. 2019;8(1):1555419.

L. G. Rikkert, R. Nieuwland, L. W. M. M. Terstappen, and F. A. W. Coumans, “Quality of extracellular vesicle images by transmission electron microscopy is operator and protocol dependent,” J. Extracell. Vesicles, vol. 8, no. 1, pp. 1555419, Jan. 2019.

Rikkert LG, Nieuwland R, Terstappen LWMM, Coumans FAW. Quality of extracellular vesicle images by transmission electron microscopy is operator and protocol dependent. J Extracell Vesicles. 2019 Jan;8(1):1555419.

Gasecka, A.; Nieuwland, R.; van der Pol, E.; Hajji, N.; Ćwiek, A.; Pluta, K.; Konwerski, M.; Filipiak, K. J. P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets. Cardiol. J. 2019, 26 (6), 782-789.

Gasecka A, Nieuwland R, van der Pol E, et al. P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets. Cardiol J. 2019;26(6):782-789.

A. Gasecka et al., “P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets,” Cardiol. J., vol. 26, no. 6, pp. 782-789, Nov. 2019.

Gasecka A, Nieuwland R, van der Pol E, Hajji N, Ćwiek A, Pluta K, et al. P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets. Cardiol J. 2019 Nov;26(6):782-9.

Cossarizza, A.; Chang, H.; Radbruch, A.; Acs, A.; Adam, D.; Adam-Klages, S.; Agace, W. W.; Aghaeepour, N.; Akdis, M.; Allez, M.; et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). Eur. J. Immunol. 2019, 49 (10), 1457-1973.

Cossarizza A, Chang H, Radbruch A, et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). Eur J Immunol. 2019;49(10):1457-1973.

A. Cossarizza et al., “Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition),” Eur. J. Immunol., vol. 49, no. 10, pp. 1457-1973, Oct.. 2019.

Cossarizza A, Chang H, Radbruch A, Acs A, Adam D, Adam-Klages S, et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). Eur J Immunol. 2019 Oct.;49(10):1457-973.

de Rond, L.; Libregts, S. F. W. M.; Rikkert, L. G.; Hau, C. M.; van der Pol, E.; Nieuwland, R.; van Leeuwen, T. G.; Coumans, F. A. W. Refractive index to evaluate staining specificity of extracellular vesicles by flow cytometry. J. Extracell. Vesicles 2019, 8, 1643671.

de Rond L, Libregts SFWM, Rikkert LG, et al. Refractive index to evaluate staining specificity of extracellular vesicles by flow cytometry. J Extracell Vesicles. 2019;8:1643671.

L. de Rond et al., “Refractive index to evaluate staining specificity of extracellular vesicles by flow cytometry,” J. Extracell. Vesicles, vol. 8, pp. 1643671, Jul. 2019.

de Rond L, Libregts SFWM, Rikkert LG, Hau CM, van der Pol E, Nieuwland R, et al. Refractive index to evaluate staining specificity of extracellular vesicles by flow cytometry. J Extracell Vesicles. 2019 Jul;8:1643671.

Pieragostino, D.; Lanuti, P.; Cicalini, I.; Cufaro, M. C.; Ciccocioppo, F.; Ronci, M.; Simeone, P.; Onofrj, M.; van der Pol, E.; Fontana, A.; et al. Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis. J. Proteomics 2019, 204, 103403.

Pieragostino D, Lanuti P, Cicalini I, et al. Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis. J Proteomics. 2019;204:103403.

D. Pieragostino et al., “Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis,” J. Proteomics, vol. 204, pp. 103403, Jul. 2019.

Pieragostino D, Lanuti P, Cicalini I, Cufaro MC, Ciccocioppo F, Ronci M, et al. Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis. J Proteomics. 2019 Jul;204:103403.

Geeurickx, E.; Tulkens, J.; Dhondt, B.; Van Deun, J.; Lippens, L.; Vergauwen, G.; Heyrman, E.; De Sutter, D.; Gevaert, K.; Impens, F.; et al. The generation and use of recombinant extracellular vesicles as biological reference material. Nat. Commun. 2019, 10 (1), 1-12.

Geeurickx E, Tulkens J, Dhondt B, et al. The generation and use of recombinant extracellular vesicles as biological reference material. Nat Commun. 2019;10(1):1-12.

E. Geeurickx et al., “The generation and use of recombinant extracellular vesicles as biological reference material,” Nat. Commun., vol. 10, no. 1, pp. 1-12, Jun. 2019.

Geeurickx E, Tulkens J, Dhondt B, Van Deun J, Lippens L, Vergauwen G, et al. The generation and use of recombinant extracellular vesicles as biological reference material. Nat Commun. 2019 Jun;10(1):1-2.

Rank, A.; Nieuwland, R.; Köhler, A.; Franz, C.; Waidhauser, J.; Toth, B. Human bone marrow contains high levels of extracellular vesicles in a tissue-specific subtype distribution. Plos One 2018, 13 (12), 1-11.

Rank A, Nieuwland R, Köhler A, Franz C, Waidhauser J, Toth B. Human bone marrow contains high levels of extracellular vesicles in a tissue-specific subtype distribution. Plos One. 2018;13(12):1-11.

A. Rank, R. Nieuwland, A. Köhler, C. Franz, J. Waidhauser, and B. Toth, “Human bone marrow contains high levels of extracellular vesicles in a tissue-specific subtype distribution,” Plos One, vol. 13, no. 12, pp. 1-11, Dec. 2018.

Rank A, Nieuwland R, Köhler A, Franz C, Waidhauser J, Toth B. Human bone marrow contains high levels of extracellular vesicles in a tissue-specific subtype distribution. Plos One. 2018 Dec;13(12):1-11.

Nieuwland, R.; Falcon-Perez, J. M.; Soekmadji, C.; Boilard, E.; Carter, D.; Buzas, E. I. Essentials of extracellular vesicles: posters on basic and clinical aspects of extracellular vesicles. J. Extracell. Vesicles 2018, 7 (1), 1548234.

Nieuwland R, Falcon-Perez JM, Soekmadji C, Boilard E, Carter D, Buzas EI. Essentials of extracellular vesicles: posters on basic and clinical aspects of extracellular vesicles. J Extracell Vesicles. 2018;7(1):1548234.

R. Nieuwland, J. M. Falcon-Perez, C. Soekmadji, E. Boilard, D. Carter, and E. I. Buzas, “Essentials of extracellular vesicles: posters on basic and clinical aspects of extracellular vesicles,” J. Extracell. Vesicles, vol. 7, no. 1, pp. 1548234, Nov. 2018.

Nieuwland R, Falcon-Perez JM, Soekmadji C, Boilard E, Carter D, Buzas EI. Essentials of extracellular vesicles: posters on basic and clinical aspects of extracellular vesicles. J Extracell Vesicles. 2018 Nov;7(1):1548234.

Théry, C.; Witwer, K. W.; Aikawa, E.; Alcaraz, M. J.; Anderson, J. D.; Andriantsitohaina, R.; Antoniou, A.; Arab, T.; Archer, F.; Atkin-Smith, G. K.; et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 2018, 7 (1), 1535750.

Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.

C. Théry et al., “Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines,” J. Extracell. Vesicles, vol. 7, no. 1, pp. 1535750, Sep. 2018.

Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018 Sep;7(1):1535750.

Yu, Y.; Gool, E.; Berckmans, R. J.; Coumans, F. A. W.; Barendrecht, A. D.; Maas, C.; van der Wel, N. N.; Altevogt, P.; Sturk, A.; Nieuwland, R. Extracellular vesicles from human saliva promote hemostasis by delivering coagulant tissue factor to activated platelets. J. Thromb. Haemost. 2018, 16 (6), 1153-1163.

Yu Y, Gool E, Berckmans RJ, et al. Extracellular vesicles from human saliva promote hemostasis by delivering coagulant tissue factor to activated platelets. J Thromb Haemost. 2018;16(6):1153-1163.

Y. Yu et al., “Extracellular vesicles from human saliva promote hemostasis by delivering coagulant tissue factor to activated platelets,” J. Thromb. Haemost., vol. 16, no. 6, pp. 1153-1163, Jun. 2018.

Yu Y, Gool E, Berckmans RJ, Coumans FAW, Barendrecht AD, Maas C, et al. Extracellular vesicles from human saliva promote hemostasis by delivering coagulant tissue factor to activated platelets. J Thromb Haemost. 2018 Jun;16(6):1153-1163.

van Es, N.; Hisada, Y.; Di Nisio, M.; Cesarman, G.; Kleinjan, A.; Mahé, I.; Otten, H.; Kamphuisen, P. W.; Berckmans, R. J.; Büller, H. R.; et al. Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study. Thromb. Res. 2018, 166, 54-59.

van Es N, Hisada Y, Di Nisio M, et al. Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study. Thromb Res. 2018;166:54-59.

N. van Es et al., “Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study,” Thromb. Res., vol. 166, pp. 54-59, Jun. 2018.

van Es N, Hisada Y, Di Nisio M, Cesarman G, Kleinjan A, Mahé I, et al. Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study. Thromb Res. 2018 Jun;166:54-59.

Peters, A. L.; Vlaar, A. P. J.; van Bruggen, R.; de Korte, D.; Meijers, J. C. M.; Nieuwland, R.; Juffermans, N. P. Transfusion of autologous extracellular vesicles from stored red blood cells does not affect coagulation in a model of human endotoxemia. Transfusion 2018, 58 (6), 1486-1493.

Peters AL, Vlaar APJ, van Bruggen R, et al. Transfusion of autologous extracellular vesicles from stored red blood cells does not affect coagulation in a model of human endotoxemia. Transfusion. 2018;58(6):1486-1493.

A. L. Peters et al., “Transfusion of autologous extracellular vesicles from stored red blood cells does not affect coagulation in a model of human endotoxemia,” Transfusion, vol. 58, no. 6, pp. 1486-1493, Jun. 2018.

Peters AL, Vlaar APJ, van Bruggen R, de Korte D, Meijers JCM, Nieuwland R, et al. Transfusion of autologous extracellular vesicles from stored red blood cells does not affect coagulation in a model of human endotoxemia. Transfusion. 2018 Jun;58(6):1486-1493.

Clayton, A.; Buschmann, D.; Byrd, J. B.; Carter, D. R. F.; Cheng, L.; Compton, C.; Daaboul, G.; Devitt, A.; Falcon-Perez, J. M.; Gardiner, C.; et al. Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017. J. Extracell. Vesicles 2018, 7 (1), 1473707.

Clayton A, Buschmann D, Byrd JB, et al. Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017. J Extracell Vesicles. 2018;7(1):1473707.

A. Clayton et al., “Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017,” J. Extracell. Vesicles, vol. 7, no. 1, pp. 1473707, May. 2018.

Clayton A, Buschmann D, Byrd JB, Carter DRF, Cheng L, Compton C, et al. Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017. J Extracell Vesicles. 2018 May;7(1):1473707.

Smit, K. F.; Konkel, M.; Kerindongo, R.; Landau, M. A.; Zuurbier, C. J.; Hollmann, M. W.; Preckel, B.; Nieuwland, R.; Albrecht, M.; Weber, N. C. Helium alters the cytoskeleton and decreases permeability in endothelial cells cultured in vitro through a pathway involving Caveolin-1. Sci. Rep. 2018, 8 (4768), .

Smit KF, Konkel M, Kerindongo R, et al. Helium alters the cytoskeleton and decreases permeability in endothelial cells cultured in vitro through a pathway involving Caveolin-1. Sci Rep. 2018;8(4768):.

K. F. Smit et al., “Helium alters the cytoskeleton and decreases permeability in endothelial cells cultured in vitro through a pathway involving Caveolin-1,” Sci. Rep., vol. 8, no. 4768, pp. , Mar. 2018.

Smit KF, Konkel M, Kerindongo R, Landau MA, Zuurbier CJ, Hollmann MW, et al. Helium alters the cytoskeleton and decreases permeability in endothelial cells cultured in vitro through a pathway involving Caveolin-1. Sci Rep. 2018 Mar;8(4768):.

van Baal, J. O. A. M.; van Noorden, C. J. F.; Nieuwland, R.; van de Vijver, K. K.; Sturk, A.; van Driel, W. J.; Kenter, G. G.; Lok, C. A. R. Development of peritoneal carcinomatosis in epithelial ovarian cancer: a review. J. Histochem. Cytochem. 2018, 66 (2), 67-83.

van Baal JOAM, van Noorden CJF, Nieuwland R, et al. Development of peritoneal carcinomatosis in epithelial ovarian cancer: a review. J Histochem Cytochem. 2018;66(2):67-83.

J. O. A. M. van Baal et al., “Development of peritoneal carcinomatosis in epithelial ovarian cancer: a review,” J. Histochem. Cytochem., vol. 66, no. 2, pp. 67-83, Feb. 2018.

van Baal JOAM, van Noorden CJF, Nieuwland R, van de Vijver KK, Sturk A, van Driel WJ, et al. Development of peritoneal carcinomatosis in epithelial ovarian cancer: a review. J Histochem Cytochem. 2018 Feb;66(2):67-83.

Karimi, N.; Cvjetkovic, A.; Jang, S. C.; Crescitelli, R.; Ali Hosseinpour Feizi, M.; Nieuwland, R.; Lötvall, J.; Lässer, C. Detailed analysis of the plasma extracellular vesicle proteome after sepraration from lipoproteins. Cell. Mol. Life Sci. 2018, 75 (15), 2873-2886.

Karimi N, Cvjetkovic A, Jang SC, et al. Detailed analysis of the plasma extracellular vesicle proteome after sepraration from lipoproteins. Cell Mol Life Sci. 2018;75(15):2873-2886.

N. Karimi et al., “Detailed analysis of the plasma extracellular vesicle proteome after sepraration from lipoproteins,” Cell. Mol. Life Sci., vol. 75, no. 15, pp. 2873-2886, Feb. 2018.

Karimi N, Cvjetkovic A, Jang SC, Crescitelli R, Ali Hosseinpour Feizi M, Nieuwland R, et al. Detailed analysis of the plasma extracellular vesicle proteome after sepraration from lipoproteins. Cell Mol Life Sci. 2018 Feb;75(15):2873-2886.

Rikkert, L. G.; van der Pol, E.; van Leeuwen, T. G.; Nieuwland, R.; Coumans, F. A. Centrifugation affects the purity of liquid biopsy-based tumor biomarkers. Cytom. Part A 2018, 93 (12), 1207-1212.

Rikkert LG, van der Pol E, van Leeuwen TG, Nieuwland R, Coumans FA. Centrifugation affects the purity of liquid biopsy-based tumor biomarkers. Cytom Part A. 2018;93(12):1207-1212.

L. G. Rikkert, E. van der Pol, T. G. van Leeuwen, R. Nieuwland, and F. A. Coumans, “Centrifugation affects the purity of liquid biopsy-based tumor biomarkers,” Cytom. Part A, vol. 93, no. 12, pp. 1207-1212, Dec. 2018.

Rikkert LG, van der Pol E, van Leeuwen TG, Nieuwland R, Coumans FA. Centrifugation affects the purity of liquid biopsy-based tumor biomarkers. Cytom Part A. 2018 Dec;93(12):1207-12.

Gąsecka, A.; van der Pol, E.; Nieuwland, R.; Stępień, E. Extracellular vesicles in post-infarct ventricular remodelling. Kardiol. Pol. 2018, 76 (1), 69-76.

Gąsecka A, van der Pol E, Nieuwland R, Stępień E. Extracellular vesicles in post-infarct ventricular remodelling. Kardiol Pol. 2018;76(1):69-76.

A. Gąsecka, E. van der Pol, R. Nieuwland, and E. Stępień, “Extracellular vesicles in post-infarct ventricular remodelling,” Kardiol. Pol., vol. 76, no. 1, pp. 69-76, Oct. 2018.

Gąsecka A, van der Pol E, Nieuwland R, Stępień E. Extracellular vesicles in post-infarct ventricular remodelling. Kardiol Pol. 2018 Oct;76(1):69-6.

de Rond, L.; Coumans, F. A. W.; Nieuwland, R.; van Leeuwen, T. G.; van der Pol, E. Deriving extracellular vesicle size from scatter intensities measured by flow cytometry. Curr. Protoc. Cytom. 2018, 86 (1), e43.

de Rond L, Coumans FAW, Nieuwland R, van Leeuwen TG, van der Pol E. Deriving extracellular vesicle size from scatter intensities measured by flow cytometry. Curr Protoc Cytom. 2018;86(1):e43.

L. de Rond, F. A. W. Coumans, R. Nieuwland, T. G. van Leeuwen, and E. van der Pol, “Deriving extracellular vesicle size from scatter intensities measured by flow cytometry,” Curr. Protoc. Cytom., vol. 86, no. 1, pp. e43, Aug. 2018.

de Rond L, Coumans FAW, Nieuwland R, van Leeuwen TG, van der Pol E. Deriving extracellular vesicle size from scatter intensities measured by flow cytometry. Curr Protoc Cytom. 2018 Aug;86(1):e43.

Varga, Z.; van der Pol, E.; Pálmai, M.; Garcia-Diez, R.; Gollwitzer, C.; Krumrey, M.; Fraikin, J.; Gasecka, A.; Hajji, N.; van Leeuwen, T. G.; et al. Hollow organosilica beads as reference particles for optical detection of extracellular vesicles. J. Thromb. Haemost. 2018, 16 (8), 1646-1655.

Varga Z, van der Pol E, Pálmai M, et al. Hollow organosilica beads as reference particles for optical detection of extracellular vesicles. J Thromb Haemost. 2018;16(8):1646-1655.

Z. Varga et al., “Hollow organosilica beads as reference particles for optical detection of extracellular vesicles,” J. Thromb. Haemost., vol. 16, no. 8, pp. 1646-1655, Jun. 2018.

Varga Z, van der Pol E, Pálmai M, Garcia-Diez R, Gollwitzer C, Krumrey M, et al. Hollow organosilica beads as reference particles for optical detection of extracellular vesicles. J Thromb Haemost. 2018 Jun;16(8):1646-55.

van der Pol, E.; de Rond, L.; Coumans, F. A. W.; Gool, E. L.; Böing, A. N.; Sturk, A.; Nieuwland, R.; van Leeuwen, T. G. Absolute sizing and label-free identification of extracellular vesicles by flow cytometry. Nanomed. Nanotechnol. 2018, 14 (3), 801-810.

van der Pol E, de Rond L, Coumans FAW, et al. Absolute sizing and label-free identification of extracellular vesicles by flow cytometry. Nanomed Nanotechnol. 2018;14(3):801-810.

E. van der Pol et al., “Absolute sizing and label-free identification of extracellular vesicles by flow cytometry,” Nanomed. Nanotechnol., vol. 14, no. 3, pp. 801-810, Apr. 2018.

van der Pol E, de Rond L, Coumans FAW, Gool EL, Böing AN, Sturk A, et al. Absolute sizing and label-free identification of extracellular vesicles by flow cytometry. Nanomed Nanotechnol. 2018 Apr;14(3):801-10.

de Rond, L.; van der Pol, E.; Hau, C. M.; Varga, Z.; Sturk, A.; van Leeuwen, T. G.; Nieuwland, R.; Coumans, F. A. W. Comparison of generic fluorescent markers for detection of extracellular vesicles by flow cytometry. Clin. Chem. 2018, 64 (4), 680-689.

de Rond L, van der Pol E, Hau CM, et al. Comparison of generic fluorescent markers for detection of extracellular vesicles by flow cytometry. Clin Chem. 2018;64(4):680-689.

L. de Rond et al., “Comparison of generic fluorescent markers for detection of extracellular vesicles by flow cytometry,” Clin. Chem., vol. 64, no. 4, pp. 680-689, Apr. 2018.

de Rond L, van der Pol E, Hau CM, Varga Z, Sturk A, van Leeuwen TG, et al. Comparison of generic fluorescent markers for detection of extracellular vesicles by flow cytometry. Clin Chem. 2018 Apr;64(4):680-9.

van der Pol, E.; Sturk, A.; van Leeuwen, T.; Nieuwland, R.; Coumans, F.; , S. W. G. Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation. J. Thromb. Haemost. 2018, 16 (6), 1236-1245.

van der Pol E, Sturk A, van Leeuwen T, Nieuwland R, Coumans F, SWG. Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation. J Thromb Haemost. 2018;16(6):1236-1245.

E. van der Pol, A. Sturk, T. van Leeuwen, R. Nieuwland, F. Coumans, and S. W. G. , “Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation,” J. Thromb. Haemost., vol. 16, no. 6, pp. 1236-1245, Mar. 2018.

van der Pol E, Sturk A, van Leeuwen T, Nieuwland R, Coumans F, SWG. Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation. J Thromb Haemost. 2018 Mar;16(6):1236-45.

Witwer, K. W.; Soekmadji, C.; Hill, A. F.; Wauben, M. H.; Buzás, E. I.; Di Vizio, D.; Falcon-Perez, J. M.; Gardiner, C.; Hochberg, F.; Kurochkin, I. V.; et al. Updating the MISEV minimal requirements for extracellular vesicle studies: building bridges to reproducibility. J. Extracell. Vesicles 2017, 6 (1), 1396823.

Witwer KW, Soekmadji C, Hill AF, et al. Updating the MISEV minimal requirements for extracellular vesicle studies: building bridges to reproducibility. J Extracell Vesicles. 2017;6(1):1396823.

K. W. Witwer et al., “Updating the MISEV minimal requirements for extracellular vesicle studies: building bridges to reproducibility,” J. Extracell. Vesicles, vol. 6, no. 1, pp. 1396823, Dec. 2017.

Witwer KW, Soekmadji C, Hill AF, Wauben MH, Buzás EI, Di Vizio D, et al. Updating the MISEV minimal requirements for extracellular vesicle studies: building bridges to reproducibility. J Extracell Vesicles. 2017 Dec;6(1):1396823.

Gool, E. L.; Stojanovic, I.; Schasfoort, R. B.; Sturk, A.; van Leeuwen, T. G.; Nieuwland, R.; Terstappen, L. W.; Coumans, F. A. Surface Plasmon Resonance is an Analytically Sensitive Method for Antigen Profiling of Extracellular Vesicles. Clin. Chem. 2017, 63 (10), 1633-1641.

Gool EL, Stojanovic I, Schasfoort RB, et al. Surface Plasmon Resonance is an Analytically Sensitive Method for Antigen Profiling of Extracellular Vesicles. Clin Chem. 2017;63(10):1633-1641.

E. L. Gool et al., “Surface Plasmon Resonance is an Analytically Sensitive Method for Antigen Profiling of Extracellular Vesicles,” Clin. Chem., vol. 63, no. 10, pp. 1633-1641, Oct. 2017.

Gool EL, Stojanovic I, Schasfoort RB, Sturk A, van Leeuwen TG, Nieuwland R, et al. Surface Plasmon Resonance is an Analytically Sensitive Method for Antigen Profiling of Extracellular Vesicles. Clin Chem. 2017 Oct;63(10):1633-1641.

van Es, N.; Di Nisio, M.; Cesarman, G.; Kleinjan, A.; Otten, H.; Mahé, I.; Wilts, I. T.; Twint, D. C.; Porreca, E.; Arrieta, O.; et al. Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study. Haematologica 2017, 102 (9), 1494-1501.

van Es N, Di Nisio M, Cesarman G, et al. Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study. Haematologica. 2017;102(9):1494-1501.

N. van Es et al., “Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study,” Haematologica, vol. 102, no. 9, pp. 1494-1501, Sep. 2017.

van Es N, Di Nisio M, Cesarman G, Kleinjan A, Otten H, Mahé I, et al. Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study. Haematologica. 2017 Sep;102(9):1494-1501.

van Hezel, M. E.; Nieuwland, R.; van Bruggen, R.; Juffermans, N. P. The ability of extracellular vesicles to induce a pro-inflammatory host response. Int. J. Mol. Sci. 2017, 18 (6), 1285.

van Hezel ME, Nieuwland R, van Bruggen R, Juffermans NP. The ability of extracellular vesicles to induce a pro-inflammatory host response. Int J Mol Sci. 2017;18(6):1285.

M. E. van Hezel, R. Nieuwland, R. van Bruggen, and N. P. Juffermans, “The ability of extracellular vesicles to induce a pro-inflammatory host response,” Int. J. Mol. Sci., vol. 18, no. 6, pp. 1285, Jun. 2017.

van Hezel ME, Nieuwland R, van Bruggen R, Juffermans NP. The ability of extracellular vesicles to induce a pro-inflammatory host response. Int J Mol Sci. 2017 Jun;18(6):1285.

Ridger, V. C.; Boulanger, C. M.; Angelillo-Scherrer, A.; Badimon, L.; Blanc-Brude, O.; Bochaton-Piallat, M.; Boilard, E.; Buzas, E. I.; Caporali, A.; Dignat-George, F.; et al. Microvesicles in vascular homeostasis and diseases. Thromb. Haemost. 2017, 117 (07), 1296-1316.

Ridger VC, Boulanger CM, Angelillo-Scherrer A, et al. Microvesicles in vascular homeostasis and diseases. Thromb Haemost. 2017;117(07):1296-1316.

V. C. Ridger et al., “Microvesicles in vascular homeostasis and diseases,” Thromb. Haemost., vol. 117, no. 07, pp. 1296-1316, Jun. 2017.

Ridger VC, Boulanger CM, Angelillo-Scherrer A, Badimon L, Blanc-Brude O, Bochaton-Piallat M, et al. Microvesicles in vascular homeostasis and diseases. Thromb Haemost. 2017 Jun;117(07):1296-1316.

Gasecka, A.; Böing, A. N.; Filipiak, K. J.; Nieuwland, R. Platelet extracellular vesicles as biomarkers for arterial thrombosis. Platelets 2017, 28 (3), 228-234.

Gasecka A, Böing AN, Filipiak KJ, Nieuwland R. Platelet extracellular vesicles as biomarkers for arterial thrombosis. Platelets. 2017;28(3):228-234.

A. Gasecka, A. N. Böing, K. J. Filipiak, and R. Nieuwland, “Platelet extracellular vesicles as biomarkers for arterial thrombosis,” Platelets, vol. 28, no. 3, pp. 228-234, May. 2017.

Gasecka A, Böing AN, Filipiak KJ, Nieuwland R. Platelet extracellular vesicles as biomarkers for arterial thrombosis. Platelets. 2017 May;28(3):228-234.

Coumans, F. A. W.; Gool, E. L.; Nieuwland, R. Bulk immunoassays for analysis of extracellular vesicles. Platelets 2017, 28 (3), 242-248.

Coumans FAW, Gool EL, Nieuwland R. Bulk immunoassays for analysis of extracellular vesicles. Platelets. 2017;28(3):242-248.

F. A. W. Coumans, E. L. Gool, and R. Nieuwland, “Bulk immunoassays for analysis of extracellular vesicles,” Platelets, vol. 28, no. 3, pp. 242-248, May. 2017.

Coumans FAW, Gool EL, Nieuwland R. Bulk immunoassays for analysis of extracellular vesicles. Platelets. 2017 May;28(3):242-248.

Van Baal, J. O. A. M.; Van de Vijver, K. K.; Nieuwland, R.; Van Noorden, C. J. F.; Van Driel, W. J.; Sturk, A.; Kenter, G. G.; Rikkert, L. G.; Lok, C. A. R. The histophysiology and pathophysiology of the peritoneum. Tissue Cell 2017, 49 (1), 95-105.

Van Baal JOAM, Van de Vijver KK, Nieuwland R, et al. The histophysiology and pathophysiology of the peritoneum. Tissue Cell. 2017;49(1):95-105.

J. O. A. M. Van Baal et al., “The histophysiology and pathophysiology of the peritoneum,” Tissue Cell, vol. 49, no. 1, pp. 95-105, Feb. 2017.

Van Baal JOAM, Van de Vijver KK, Nieuwland R, Van Noorden CJF, Van Driel WJ, Sturk A, et al. The histophysiology and pathophysiology of the peritoneum. Tissue Cell. 2017 Feb;49(1):95-105.

Sebaihi, N.; De Boeck, B.; Yuana, Y.; Nieuwland, R.; Pétry, J. Dimensional characterization of extracellular vesicles using atomic force microscopy. Meas. Sci. Technol. 2017, 28 (3), 034006.

Sebaihi N, De Boeck B, Yuana Y, Nieuwland R, Pétry J. Dimensional characterization of extracellular vesicles using atomic force microscopy. Meas Sci Technol. 2017;28(3):034006.

N. Sebaihi, B. De Boeck, Y. Yuana, R. Nieuwland, and J. Pétry, “Dimensional characterization of extracellular vesicles using atomic force microscopy,” Meas. Sci. Technol., vol. 28, no. 3, pp. 034006, Jan. 2017.

Sebaihi N, De Boeck B, Yuana Y, Nieuwland R, Pétry J. Dimensional characterization of extracellular vesicles using atomic force microscopy. Meas Sci Technol. 2017 Jan;28(3):034006.

Cointe, S.; Judicone, C.; Robert, S.; Mooberry, M. J.; Poncelet, P.; Wauben, M.; Nieuwland, R.; Key, N. S.; Dignat-George, F.; Lacroix, R. Standardization of microparticle enumeration across different flow cytometry platforms: results of a multicenter collaborative workshop. J. Thromb. Haemost. 2017, 15 (1), 187-193.

Cointe S, Judicone C, Robert S, et al. Standardization of microparticle enumeration across different flow cytometry platforms: results of a multicenter collaborative workshop. J Thromb Haemost. 2017;15(1):187-193.

S. Cointe et al., “Standardization of microparticle enumeration across different flow cytometry platforms: results of a multicenter collaborative workshop,” J. Thromb. Haemost., vol. 15, no. 1, pp. 187-193, Jan. 2017.

Cointe S, Judicone C, Robert S, Mooberry MJ, Poncelet P, Wauben M, et al. Standardization of microparticle enumeration across different flow cytometry platforms: results of a multicenter collaborative workshop. J Thromb Haemost. 2017 Jan;15(1):187-193.

van der Pol, E.; Harrison, P. From platelet dust to gold dust: physiological importance and detection of platelet microvesicles. Platelets 2017, 28 (3), 211-213.

van der Pol E, Harrison P. From platelet dust to gold dust: physiological importance and detection of platelet microvesicles. Platelets. 2017;28(3):211-213.

E. van der Pol, and P. Harrison, “From platelet dust to gold dust: physiological importance and detection of platelet microvesicles,” Platelets, vol. 28, no. 3, pp. 211-213, May. 2017.

van der Pol E, Harrison P. From platelet dust to gold dust: physiological importance and detection of platelet microvesicles. Platelets. 2017 May;28(3):211-3.

Coumans, F. A. W.; Brisson, A. R.; Buzas, E. I.; Dignat-George, F.; Drees, E. E. E.; El-Andaloussi, S.; Emanueli, C.; Gasecka, A.; Hendrix, A.; Hill, A. F.; et al. Methodological guidelines to study extracellular vesicles. Circ. Res. 2017, 120 (10), 1632-1648.

Coumans FAW, Brisson AR, Buzas EI, et al. Methodological guidelines to study extracellular vesicles. Circ Res. 2017;120(10):1632-1648.

F. A. W. Coumans et al., “Methodological guidelines to study extracellular vesicles,” Circ. Res., vol. 120, no. 10, pp. 1632-1648, May. 2017.

Coumans FAW, Brisson AR, Buzas EI, Dignat-George F, Drees EEE, El-Andaloussi S, et al. Methodological guidelines to study extracellular vesicles. Circ Res. 2017 May;120(10):1632-48.

Valkonen, S.; van der Pol, E.; Böing, A.; Yuana, Y.; Yliperttula, M.; Nieuwland, R.; Laitinen, S.; Siljander, P. R. M. Biological reference materials for extracellular vesicle studies. Eur. J. Pharm. Sci. 2017, 98, 4-16.

Valkonen S, van der Pol E, Böing A, et al. Biological reference materials for extracellular vesicle studies. Eur J Pharm Sci. 2017;98:4-16.

S. Valkonen et al., “Biological reference materials for extracellular vesicle studies,” Eur. J. Pharm. Sci., vol. 98, pp. 4-16, Feb. 2017.

Valkonen S, van der Pol E, Böing A, Yuana Y, Yliperttula M, Nieuwland R, et al. Biological reference materials for extracellular vesicle studies. Eur J Pharm Sci. 2017 Feb;98:4-6.

Straat, M.; van Hezel, M. E.; Böing, A.; Tuip-De Boer, A.; Weber, N.; Nieuwland, R.; van Bruggen, R.; Juffermans, N. P. Monocyte-mediated activation of endothelial cells occurs only after binding to extracellular vesicles from red blood cell products, a process mediated by beta-integrin. Transfusion 2016, 56 (12), 3012-3020.

Straat M, van Hezel ME, Böing A, et al. Monocyte-mediated activation of endothelial cells occurs only after binding to extracellular vesicles from red blood cell products, a process mediated by beta-integrin. Transfusion. 2016;56(12):3012-3020.

M. Straat et al., “Monocyte-mediated activation of endothelial cells occurs only after binding to extracellular vesicles from red blood cell products, a process mediated by beta-integrin,” Transfusion, vol. 56, no. 12, pp. 3012-3020, Dec. 2016.

Straat M, van Hezel ME, Böing A, Tuip-De Boer A, Weber N, Nieuwland R, et al. Monocyte-mediated activation of endothelial cells occurs only after binding to extracellular vesicles from red blood cell products, a process mediated by beta-integrin. Transfusion. 2016 Dec;56(12):3012-3020.

van Eijndhoven, M. A. J.; Zijlstra, J. M.; Groenewegen, N. J.; Drees, E. E. E.; van Niele, S.; Baglio, S. R.; Koppers-Lalic, D.; van der Voorn, H.; Libregts, S. F. W. M.; Wauben, M. H. M.; et al. Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients. JCI Insight 2016, 1 (19), e89631.

van Eijndhoven MAJ, Zijlstra JM, Groenewegen NJ, et al. Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients. JCI Insight. 2016;1(19):e89631.

M. A. J. van Eijndhoven et al., “Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients,” JCI Insight, vol. 1, no. 19, pp. e89631, Nov. 2016.

van Eijndhoven MAJ, Zijlstra JM, Groenewegen NJ, Drees EEE, van Niele S, Baglio SR, et al. Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients. JCI Insight. 2016 Nov;1(19):e89631.

Franz, C.; Böing, A. N.; Montag, M.; Strowitzki, T.; Markert, U. R.; Mastenbroek, S.; Nieuwland, R.; Toth, B. Extracellular vesicles in human follicular fluid do not promote coagulation. Reprod. Biomed. Online 2016, 33 (5), 652-655.

Franz C, Böing AN, Montag M, et al. Extracellular vesicles in human follicular fluid do not promote coagulation. Reprod Biomed Online. 2016;33(5):652-655.

C. Franz et al., “Extracellular vesicles in human follicular fluid do not promote coagulation,” Reprod. Biomed. Online, vol. 33, no. 5, pp. 652-655, Nov. 2016.

Franz C, Böing AN, Montag M, Strowitzki T, Markert UR, Mastenbroek S, et al. Extracellular vesicles in human follicular fluid do not promote coagulation. Reprod Biomed Online. 2016 Nov;33(5):652-655.